Your browser doesn't support javascript.
loading
Predictors of functional impairment in bipolar disorder: Results from 13 cohorts from seven countries by the global bipolar cohort collaborative.
Burdick, Katherine E; Millett, Caitlin E; Yocum, Anastasia K; Altimus, Cara M; Andreassen, Ole A; Aubin, Valerie; Belzeaux, Raoul; Berk, Michael; Biernacka, Joanna M; Blumberg, Hilary P; Cleare, Anthony J; Diaz-Byrd, Claudia; Dubertret, Caroline; Etain, Bruno; Eyler, Lisa T; Forester, Brent P; Fullerton, Janice M; Frye, Mark A; Gard, Sébastien; Godin, Ophelia; Haffen, Emmanuel; Klaus, Federica; Lagerberg, Trine Vik; Leboyer, Marion; Martinez-Aran, Anabel; McElroy, Susan; Mitchell, Philip B; Olie, Emilie; Olorunfemi, Phebe; Passerieux, Christine; Peters, Amy T; Pham, Daniel L; Polosan, Mircea; Potter, Julia R; Sajatovic, Martha; Samalin, Ludovic; Schwan, Raymund; Shanahan, Megan; Solé, Brisa; Strawbridge, Rebecca; Stuart, Amanda L; Torres, Ivan; Ueland, Torrill; Vieta, Eduard; Williams, Lana J; Wrobel, Anna L; Yatham, Lakshmi N; Young, Allan H; Nierenberg, Andrew A; McInnis, Melvin G.
Affiliation
  • Burdick KE; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Millett CE; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Yocum AK; University of Michigan, Ann Arbor, Michigan, USA.
  • Altimus CM; The Milken Institute, Washington, District of Columbia, USA.
  • Andreassen OA; NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Aubin V; KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.
  • Belzeaux R; Pôle de Psychiatrie, Centre Hospitalier Princesse Grace, Monaco, Monaco.
  • Berk M; Pôle de Psychiatrie, Assistance Publique Hôpitaux de Marseille, Marseille, France; INT-UMR7289, CNRS Aix-Marseille Université, Marseille, France.
  • Biernacka JM; Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.
  • Blumberg HP; Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia.
  • Cleare AJ; Mayo Clinic Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Diaz-Byrd C; Mayo Clinic Department of Quantitative Health Sciences, Mayo Clinic, Rocester, MN, USA.
  • Dubertret C; Yale School of Medicine, New Haven, Connecticut, USA.
  • Etain B; Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Eyler LT; University of Michigan, Ann Arbor, Michigan, USA.
  • Forester BP; Université de Paris, INSERM UMR1266, AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT, service de Psychiatrie et Addictologie, Hôpital Louis Mourier, Colombes, France.
  • Fullerton JM; Université de Paris, AP-HP, Groupe Hospitalo-universitaire AP-HP Nord, DMU Neurosciences, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, INSERM UMRS, Paris, France.
  • Frye MA; University of California San Diego, La Jolla, CA, USA.
  • Gard S; Desert-Pacific Mental Illness Research Education and Clinical Center, VA San Diego Healthcare System, San Diego, California, USA.
  • Godin O; Division of Geriatric Psychiatry, McLean Hospital, Belmont, MA, USA.
  • Haffen E; Harvard Medical School, Boston, Massachusetts, USA.
  • Klaus F; Neuroscience Research Australia, Sydney, Australia.
  • Lagerberg TV; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Leboyer M; Mayo Clinic Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Martinez-Aran A; Pôle de Psychiatrie Générale et Universitaire, Centre Hospitalier Charles Perrens, Bordeaux, France.
  • McElroy S; Univ Paris Est Créteil, INSERM U955, IMRB, Translational Neuro-Psychiatry, Fondation FondaMental, Créteil, France.
  • Mitchell PB; APHP, Hôpitaux Universitaires Henri Mondor, Département Médico-Universitaire de Psychiatrie et d'Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Créteil, France.
  • Olie E; Clinical Psychiatry Department, Treatment-Resistant Depression Fondamental Expert Center, EA 481 Neurosciences, Bourgogne Franche Comté University, Besançon, France.
  • Olorunfemi P; University of California San Diego, La Jolla, CA, USA.
  • Passerieux C; Desert-Pacific Mental Illness Research Education and Clinical Center, VA San Diego Healthcare System, San Diego, California, USA.
  • Peters AT; NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Pham DL; Univ Paris Est Créteil, INSERM U955, IMRB, Translational Neuro-Psychiatry, Fondation FondaMental, Créteil, France.
  • Polosan M; APHP, Hôpitaux Universitaires Henri Mondor, Département Médico-Universitaire de Psychiatrie et d'Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Créteil, France.
  • Potter JR; Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
  • Sajatovic M; SLM Lindner Center of HOPE, Mason, Ohio, USA.
  • Samalin L; University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Schwan R; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Shanahan M; Department of Emergency Psychiatry and Acute Care, CHU Montpellier, IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France.
  • Solé B; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Strawbridge R; Service Hospitalo-Universitaire de psychiatrie d'adulte et d'addictologie, Centre Hospitalier de Versailles, INSERM UMR1018, DisAP-DevPsy-CESP, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Gif-sur-Yvette, France.
  • Stuart AL; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Torres I; The Milken Institute, Washington, District of Columbia, USA.
  • Ueland T; Univ. Grenoble Alpes, CHU de Grenoble et des Alpes, Grenoble Institut des Neurosciences (GIN) Inserm U 1216, Grenoble, France.
  • Vieta E; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Williams LJ; University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Wrobel AL; CHU Clermont-Ferrand, Department of Psychiatry, University of Clermont Auvergne, UMR 6602 Institut Pascal (IP), Clermont-Ferrand, France.
  • Yatham LN; Université de Lorraine, Inserm U 1114, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie CPN, Laxou, France.
  • Young AH; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Nierenberg AA; Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
  • McInnis MG; Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Bipolar Disord ; 24(7): 709-719, 2022 11.
Article in En | MEDLINE | ID: mdl-35322518

Full text: 1 Database: MEDLINE Main subject: Bipolar Disorder Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Bipolar Disorder Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article